Furthermore, data about inflammatory biomarkers in patients with dual diagnosis (psychosis and addiction) are reported in scientific literature and TGFα has been proposed as a potential biomarker of this double condition [60,62,80]. This evidence concerns the gene TGFA and psychotic disorder.